400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Epigenetics / HIF / 二甲基草酰甘氨酸
CAS No.: 89464-63-1
Synonyms: Dimethyloxallyl Glycine;Dimethyloxaloylglycine
Dimethyloxallyl glycine is a cell permeable, competitive inhibitor of HIF-PH (HIF-1α prolyl hydroxylase).
生物活性
实验方案
技术信息
CAS号 | 89464-63-1 | 储存条件 |
|
|||||
分子式 | C6H9NO5 | 运输 | 蓝冰 | |||||
分子量 | 175.14 | 别名 | Dimethyloxallyl Glycine;Dimethyloxaloylglycine | |||||
溶解度 |
|
动物实验配方 |
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
human 293T cells | 2.5 mM | Function assay | - | Inhibition of JMJD2-mediated H3K36 demethylation in human 293T cells at 2.5 mM | 19359167 |
human A3-KAW cell | - | Growth inhibition assay | - | Inhibition of human A3-KAW cell growth in a cell viability assay, IC50=15.8174 μM | SANGER |
human A4-Fuk cell | - | Growth inhibition assay | - | Inhibition of human A4-Fuk cell growth in a cell viability assay, IC50=45.0364 μM | SANGER |
human BEN cell | - | Growth inhibition assay | - | Inhibition of human BEN cell growth in a cell viability assay, IC50=36.8187 μM | SANGER |
human BL-70 cell | - | Growth inhibition assay | - | Inhibition of human BL-70 cell growth in a cell viability assay, IC50=15.9423 μM | SANGER |
human CAL-12T cell | - | Growth inhibition assay | - | Inhibition of human CAL-12T cell growth in a cell viability assay, IC50=26.5502 μM | SANGER |
human CAL-39 cell | - | Growth inhibition assay | - | Inhibition of human CAL-39 cell growth in a cell viability assay, IC50=19.3277 μM | SANGER |
human CCRF-CEM cell | - | Growth inhibition assay | - | Inhibition of human CCRF-CEM cell growth in a cell viability assay, IC50=37.7729 μM | SANGER |
human COR-L105 cell | - | Growth inhibition assay | - | Inhibition of human COR-L105 cell growth in a cell viability assay, IC50=26.4436 μM | SANGER |
human DMS-273 cell | - | Growth inhibition assay | - | Inhibition of human DMS-273 cell growth in a cell viability assay, IC50=15.965 μM | SANGER |
human EB-3 cell | - | Growth inhibition assay | - | Inhibition of human EB-3 cell growth in a cell viability assay, IC50=49.5792 μM | SANGER |
human EW-13 cell | - | Growth inhibition assay | - | Inhibition of human EW-13 cell growth in a cell viability assay, IC50=39.0481 μM | SANGER |
human HH cell | - | Growth inhibition assay | - | Inhibition of human HH cell growth in a cell viability assay, IC50=34.0235 μM | SANGER |
human KE-37 cell | - | Growth inhibition assay | - | Inhibition of human KE-37 cell growth in a cell viability assay, IC50=43.2915 μM | SANGER |
human KS-1 cell | - | Growth inhibition assay | - | Inhibition of human KS-1 cell growth in a cell viability assay, IC50=11.2557 μM | SANGER |
human KU812 cell | - | Growth inhibition assay | - | Inhibition of human KU812 cell growth in a cell viability assay, IC50=28.4579 μM | SANGER |
human KYSE-410 cell | - | Growth inhibition assay | - | Inhibition of human KYSE-410 cell growth in a cell viability assay, IC50=20.8197 μM | SANGER |
human LB996-RCC cell | - | Growth inhibition assay | - | Inhibition of human LB996-RCC cell growth in a cell viability assay, IC50=5.6877 μM | SANGER |
human LC-2-ad cell | - | Growth inhibition assay | - | Inhibition of human LC-2-ad cell growth in a cell viability assay, IC50=24.5573 μM | SANGER |
human LOUCY cell | - | Growth inhibition assay | - | Inhibition of human LOUCY cell growth in a cell viability assay, IC50=10.3493 μM | SANGER |
human MLMA cell | - | Growth inhibition assay | - | Inhibition of human MLMA cell growth in a cell viability assay, IC50=46.3292 μM | SANGER |
human MZ1-PC cell | - | Growth inhibition assay | - | Inhibition of human MZ1-PC cell growth in a cell viability assay, IC50=45.9888 μM | SANGER |
human NCI-H2228 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H2228 cell growth in a cell viability assay, IC50=42.818 μM | SANGER |
human OPM-2 cell | - | Growth inhibition assay | - | Inhibition of human OPM-2 cell growth in a cell viability assay, IC50=28.8227 μM | SANGER |
human RS4-11 cell | - | Growth inhibition assay | - | Inhibition of human RS4-11 cell growth in a cell viability assay, IC50=34.1806 μM | SANGER |
human SR cell | - | Growth inhibition assay | - | Inhibition of human SR cell growth in a cell viability assay, IC50=4.57946 μM | SANGER |
human SW982 cell | - | Growth inhibition assay | - | Inhibition of human SW982 cell growth in a cell viability assay, IC50=33.7007 μM | SANGER |
human U-698-M cell | - | Growth inhibition assay | - | Inhibition of human U-698-M cell growth in a cell viability assay, IC50=13.3306 μM | SANGER |
human YT cell | - | Growth inhibition assay | - | Inhibition of human YT cell growth in a cell viability assay, IC50=23.3984 μM | SANGER |
靶点 | Description | IC50 |
---|
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网